Alzamend Neuro, Inc. (ALZN) vs IMMURON (IMRN)
Alzamend Neuro, Inc. and IMMURON are both Biotechnology companies. Alzamend Neuro, Inc. and IMMURON are of similar size ($9.6M and $8.8M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, IMMURON leads on 6 and Alzamend Neuro, Inc. on 3.
Valuation
Profitability
| Metric | ALZN | IMRN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 71.28% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (262.71%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (163.23%) | 0.00% | (57.72%) |
| Return on assets | (122.36%) | 0.00% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack